Population-based colorectal cancer screening: Interval cancers and relationship with the quantitative faecal immunological for hemoglobin
Med Clin (Barc). 2019 Apr 18;152(8):303-306.
doi: 10.1016/j.medcli.2018.06.022.
Epub 2018 Aug 23.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Epidemiología y Evaluación, Hospital del Mar, Barcelona, España; IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, España; REDISSEC (Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas), Madrid, España. Electronic address: aburon@parcdesalutmar.cat.
- 2 Servicio de Epidemiología y Evaluación, Hospital del Mar, Barcelona, España; IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, España; REDISSEC (Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas), Madrid, España.
- 3 IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, España; Servicio de Gastroenterología, Hospital del Mar, Barcelona, España.
- 4 Servicio de Gastroenterología, Hospital Clínic, Barcelona, IDIBAPS, Barcelona, España; Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, España; Universidad de Barcelona, Barcelona, España.
- 5 Universidad de Barcelona, Barcelona, España; Servicio de Preventiva y Epidemiología, ICMID, Hospital Clínic, Barcelona, España.
Abstract
Introduction and objective:
The sensitivity of colorectal cancer screening programmes determines their effectiveness and is directly related to the interval cancer (IC). This study describes the frequency and characteristics of the IC of the Programme of Barcelona, Spain, and analyses its relationship with the quantitative value of the screening test (FIT).
Material and methods:
ICs after negative FIT of the first two rounds of the Programme (2010-2013) were included, observation period until July 2017. The information source of the ICs was their notification by professionals and patients, hospital databases and CMBD (Spanish Minimum Basic Data Set).
Results:
The sensitivity of the Programme is 82%. ICs are diagnosed more in proximal and rectal colon and in advanced stages than screening cancers, and have higher FIT values than overall people with negative FIT.
Conclusions:
The sensitivity is acceptable and comparable to that of other programmes. The quantitative value of FIT in people with negative test should be included in the personalisation strategies of screening to reduce the risk of IC.
Keywords:
Colorectal neoplasms; Cribado; Cáncer colorrectal; Cáncer de intervalo; Interval cancer; Screening.
Copyright © 2018 Elsevier España, S.L.U. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Colonic Neoplasms / diagnosis*
-
Colonic Neoplasms / epidemiology
-
Colonic Neoplasms / pathology
-
Female
-
Humans
-
Male
-
Middle Aged
-
Occult Blood*
-
Program Evaluation
-
Rectal Neoplasms / diagnosis*
-
Rectal Neoplasms / epidemiology
-
Rectal Neoplasms / pathology
-
Sensitivity and Specificity
-
Spain / epidemiology
-
Time Factors